PRODUCT

Gonadorelin (2 mg Vial)

No short description available.

Quickstart Highlights

Gonadorelin dosage supports the restoration of natural LH and FSH release from the pituitary gland, reactivating the hypothalamic‑pituitary‑gonadal (HPG) axis[1]. As a synthetic form of gonadotropin‑releasing hormone (GnRH), gonadorelin stimulates testosterone production in men and promotes ovulation in women when administered in short, pulsatile doses[2][3]. This educational protocol outlines a subcutaneous micro‑dosing approach using a practical dilution for accurate insulin‑syringe measurements.

Reconstitute: Add 2.0 mL bacteriostatic water → 1 mg/mL concentration (1000 mcg/mL).
Typical dose range: 50–250 mcg per injection, 2–3 times weekly.
Easy measuring: At 1 mg/mL, 1 unit = 0.01 mL = 10 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Reconstitution

Draw 2.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label concentration (1 mg/mL) and date; refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
Label concentration (1 mg/mL) and date; refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Protocol Overview

Goal:Stimulate endogenous LH and FSH release to support testosterone production and testicular function[1][5].
Schedule:Subcutaneous injections 2–3 times weekly for 4–8 weeks; limit daily dosing to ≤14 consecutive days.
Dose Range:50–200 mcg per injection based on goals and response.
Reconstitution:2.0 mL per 2 mg vial (1 mg/mL) for accurate unit measurements.
Storage:Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosage Protocols

Start:50–100 mcg per injection; assess tolerance before increasing.
Target:100–150 mcg per injection, 2–3 times weekly.
Frequency:Non‑consecutive days (e.g., Mon/Wed/Fri) to mimic pulsatile GnRH release.
Cycle Length:4–8 weeks; include off‑periods to maintain pituitary sensitivity.
Timing:Morning injections preferred; rotate injection sites.

Storage Instructions

Lyophilized:Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
Reconstituted:Refrigerate at 2–8 °C (35.6–46.4 °F); use within 4 weeks and avoid freeze–thaw.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes; dispose in a sharps container.
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
Inject slowly; wait a few seconds before withdrawing the needle.
Document each dose, date, and site rotation to maintain consistency.
Limit continuous daily dosing to ≤14 days to prevent receptor desensitization[4].

How It Works

Gonadorelin is a synthetic decapeptide identical to endogenous gonadotropin‑releasing hormone (GnRH) secreted by the hypothalamus[1]. When administered in short, pulsatile fashion, it binds to GnRH receptors on pituitary gonadotrophs, triggering the release of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH)[2][3]. LH stimulates Leydig cells to produce testosterone in men and triggers ovulation in women, while FSH supports spermatogenesis and ovarian follicle development[5]. Unlike continuous GnRH agonist administration, which desensitizes receptors and suppresses gonadotropins, brief periodic dosing preserves the natural pulsatile signaling pattern[4][6].

Lifestyle Factors

Maintain adequate sleep (7–9 hours) to support natural hormonal rhythms.
Pair with resistance training and balanced nutrition to optimize hormonal response.
Manage stress through relaxation techniques; chronic stress can impair HPG axis function.
Avoid excessive alcohol and limit endocrine disruptors where possible.

Injection Technique

Clean the vial stopper and skin with alcohol; allow to dry.
Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[12][13].
Do not aspirate for subcutaneous injections; inject slowly and steadily[12].
Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[14].

Benefits and Side Effects

Benefits

Supports endogenous testosterone production by stimulating LH release[1][5].
May help maintain testicular volume and function during exogenous testosterone therapy[7].
Promotes spermatogenesis and fertility in hypogonadotropic hypogonadism when administered in pulsatile regimens[8][9].

Side Effects

Generally well tolerated; occasional mild injection‑site reactions (redness, itching, or swelling) may occur[10].
Possible transient headache or flushing shortly after injection[10].

Gonadorelin (2 mg Vial)

Resources

Categories

Company